Vimarsana
Biggest News Aggregation in the World

Innate Immun News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Innate Immun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Innate Immun Today - Breaking & Trending Today

Kineret® authorised for emergency use by FDA for the treatment of COVID-19 related pneumonia - Vimarsana News

Kineret® authorised for emergency use by FDA for the treatment of COVID-19 related pneumonia

Published: November 10, 2022

/PRNewswire/ -- Sobi® today announced that the US Food and Drug Administration has granted Emergency Use Authorisation (EUA) for the use of Kineret® (anakinra)...

Source: prnewswire.com
Related Topics:
United StatesAnders UllmanEvangelosj Giamarellos BourboulisAssistance CenterWorld Health OrganizationDrug AdministrationSobi Investor Relations TeamInformation ExchangeHellenic Institute For The Study Of SepsisHead Of Research DevelopmentEmergency Use AuthorisationChief Medical OfficerNature MedicineGuided Anakinra TreatmentSevere Respiratory FailureHellenic InstituteEmergency Task ForceOrgan Failure AssessmentFamilial MediterraneanSystemic Juvenile Idiopathic ArthritisAdult Onset StillCytokine Storm Is VitalTissue Specific InflammationInnate ImmunNorth America
Kineret® authorised for emergency use by FDA for the treatment of COVID-19 related pneumonia (1) - Vimarsana News

Kineret® authorised for emergency use by FDA for the treatment of COVID-19 related pneumonia (1)

Published: November 10, 2022

STOCKHOLM, Nov. 10, 2022 /PRNewswire/ -- Sobi® today announced that the US Food and Drug Administration has...

Source: europapress.es
Related Topics:
United StatesAnders UllmanEvangelosj Giamarellos BourboulisPrnewswire SobiAssistance CenterWorld Health OrganizationDrug AdministrationSobi Investor Relations TeamInformation ExchangeHellenic Institute For The Study Of SepsisHead Of Research DevelopmentEmergency Use AuthorisationChief Medical OfficerNature MedicineGuided Anakinra TreatmentSevere Respiratory FailureProfessor EvangelosHellenic InstituteEmergency Task ForceOrgan Failure AssessmentFamilial MediterraneanSystemic Juvenile Idiopathic ArthritisAdult Onset StillCytokine Storm Is VitalTissue Specific Inflammation
Swedish Orphan Biovitrum AB: Kineret authorised for emergency use by FDA for the treatment of COVID-19 related pneumonia - Vimarsana News

Swedish Orphan Biovitrum AB: Kineret authorised for emergency use by FDA for the treatment of COVID-19 related pneumonia

Published: November 10, 2022

STOCKHOLM, Nov. 10, 2022 /PRNewswire/ -- Sobi today announced that the US Food and Drug Administration has granted Emergency Use Authorisation (EUA) for the use of Kineret (anakinra) for the

Source: finanznachrichten.de
Related Topics:
United StatesAnders UllmanEvangelosj Giamarellos BourboulisPrnewswire SobiAssistance CenterWorld Health OrganizationDrug AdministrationSobi Investor Relations TeamInformation ExchangeHellenic Institute For The Study Of SepsisHead Of Research DevelopmentEmergency Use AuthorisationChief Medical OfficerNature MedicineGuided Anakinra TreatmentSevere Respiratory FailureProfessor EvangelosHellenic InstituteEmergency Task ForceOrgan Failure AssessmentFamilial MediterraneanSystemic Juvenile Idiopathic ArthritisAdult Onset StillCytokine Storm Is VitalTissue Specific Inflammation